The fall COVID-19 vaccine season is starting slowly for Pfizer, with U.S. sales of its Comirnaty shots sinking 25% after federal regulators narrowed recommendations on who should get them.
We are sharing Tech and Health related news from all around the world. hope that these content will serve the purpose.
No comments:
Post a Comment